NYSE - Delayed Quote USD

Revvity, Inc. (RVTY)

96.25
+3.37
+(3.63%)
At close: June 10 at 4:00:02 PM EDT
97.80
+1.55
+(1.61%)
Pre-Market: 4:09:36 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,769,868
2,755,026
2,750,571
3,311,822
3,827,808
Cost of Revenue
1,211,710
1,217,367
1,210,880
1,321,992
1,393,821
Gross Profit
1,558,158
1,537,659
1,539,691
1,989,830
2,433,987
Operating Expense
1,183,303
1,190,918
1,239,129
1,247,131
1,175,530
Operating Income
374,855
346,741
300,562
742,699
1,258,457
Net Non Operating Interest Income Expense
-31,660
-23,088
-26,682
-100,366
-99,887
Other Income Expense
-9,236
-7,527
-90,904
9,504
45,012
Pretax Income
333,959
316,126
182,976
651,837
1,203,582
Tax Provision
37,915
33,055
3,473
139,161
314,146
Net Income Common Stockholders
286,609
270,385
693,094
569,179
943,157
Diluted NI Available to Com Stockholders
286,609
270,385
693,094
569,179
943,157
Basic EPS
2.35
2.21
5.62
4.59
7.39
Diluted EPS
2.34
2.20
5.55
4.58
7.39
Basic Average Shares
121,933.25
122,756
123,426
126,300
126,241
Diluted Average Shares
121,995.75
122,822
124,812
126,426
126,241
Total Operating Income as Reported
374,855
346,741
300,562
742,699
1,258,457
Total Expenses
2,395,013
2,408,285
2,450,009
2,569,123
2,569,351
Net Income from Continuing & Discontinued Operation
286,609
270,385
693,094
569,179
943,157
Normalized Income
292,372.25
282,193.01
250,034.94
531,280.10
883,799.72
Interest Income
63,185
73,190
72,131
3,589
2,241
Interest Expense
94,845
96,278
98,813
103,955
102,128
Net Interest Income
-31,660
-23,088
-26,682
-100,366
-99,887
EBIT
428,804
412,404
281,789
755,792
1,305,710
EBITDA
846,273
840,253
713,558
1,182,792
1,617,153
Reconciled Cost of Revenue
1,211,710
1,217,367
1,210,880
1,321,992
1,393,821
Reconciled Depreciation
417,469
427,849
431,769
427,000
311,443
Net Income from Continuing Operation Net Minority Interest
296,044
283,071
179,503
512,676
889,436
Total Unusual Items Excluding Goodwill
4,142
981
-71,898
-23,654
7,627
Total Unusual Items
4,142
981
-71,898
-23,654
7,627
Normalized EBITDA
842,131
839,272
785,456
1,206,446
1,609,526
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
470.25
103.01
-1,366.06
-5,049.90
1,990.72
12/31/2021 - 2/21/1973

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WAT Waters Corporation
349.84
+0.43%
 
MTD Mettler-Toledo International Inc.
1,216.57
+1.77%
 
A Agilent Technologies, Inc.
120.52
+3.24%
 
QGEN Qiagen N.V.
46.22
+0.11%
 
LH Labcorp Holdings Inc.
259.37
+1.42%
 
CRL Charles River Laboratories International, Inc.
151.00
+2.40%
 
IQV IQVIA Holdings Inc.
159.77
+3.65%
 
SHC Sotera Health Company
12.30
-0.49%
 
TMO Thermo Fisher Scientific Inc.
414.54
+1.47%
 
ERF.PA Eurofins Scientific SE
59.34
+0.88%